Presentation of second quarter 2010 results
(Thomson Reuters ONE) -
6 August 2010, Lysaker, Norway: Pronova BioPharma ASA will publish the group's
second quarter 2010 results on Friday 13 August 2010.
Morten Jurs, CEO, and Synne H. Røine, CFO, will give a presentation of the
results at Hotel Continental, Stortingsgaten 24/26, Oslo at 08:30 AM CET.
Breakfast will be served from 08:00 AM CET. Participants are asked to register
at
www.pronova.com.
The presentation will also be web-casted live over the Internet and can be
accessed fromwww.pronova.com where questions can be submitted live during the
presentation. The company will host a telephone conference to listen live to the
presentation.
Please dial the following numbers:
Connection of the participants (5 minutes before the conference)
International Toll Number: UK: +
44?207?108 6205
International Toll Number: SE: +46 8?506?269 30
International Toll Number: NO: +47 21 01 09 34
No conference ID is required.
For further information, please contact:
Hamed Brodersen, Vice President Investor Relations (IR) and Communications: +47
40 46 81 10,
IR(at)pronova.com
This information is subject of the disclosure requirements acc. to §5-12 vphl
(Norwegian Securities Trading Act)
[HUG#1436504]
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
All reproduction for further distribution is prohibited.
Source: Pronova BioPharma ASA via Thomson Reuters ONE
Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: hugin
Datum: 06.08.2010 - 15:18 Uhr
Sprache: Deutsch
News-ID 39010
Anzahl Zeichen: 0
contact information:
Town:
Lysaker
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 166 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Presentation of second quarter 2010 results"
steht unter der journalistisch-redaktionellen Verantwortung von
Pronova BioPharma ASA (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).





